openPR Logo
Press release

Investigation for Investors in ANSDAQ: ENDP over possible Wrongdoing at Endo International plc (NASDAQ: ENDP)

09-25-2020 12:55 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in Endo International plc (NASDAQ: ENDP) shares.

An investigation on behalf of current long term investors in Endo International plc (NASDAQ: ENDP) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Endo International plc.

Investors who are current long term investors in Endo International plc (NASDAQ: ENDP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: ENDP stocks follows a lawsuit filed against Endo International plc over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: ENDP stocks, concerns whether certain Endo International plc directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the District of New Jersey the plaintiff alleges that, the Defendants made false and/or misleading statements and/or failed to disclose: (1) the full scope of Endo’s and/or its subsidiaries’ contributions to the opioid crisis, including, but not limited to, their opioid products’ disproportionately negative impact on New York, one of the most populous states in the U.S., as well as the fraud that Defendants perpetrated on the New York insurance market; (2) part of that contribution to the crisis included Endo publishing and disseminating false information to health care providers regarding the risks and benefits of opioids; (3) that the foregoing, once revealed, was foreseeably likely to subject Endo and/or its subsidiaries to increased regulatory scrutiny and enforcement, as well as significant financial and/or reputational harm, particularly with respect to New York; and (4) that, as a result, the Company’s public statements were materially false and misleading at all relevant times.

Those who purchased shares of Endo International plc (NASDAQ: ENDP) have certain options and should contact the Shareholders Foundation.

Media Contact:
Christopher Clausen
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation for Investors in ANSDAQ: ENDP over possible Wrongdoing at Endo International plc (NASDAQ: ENDP) here

News-ID: 2142160 • Views: 491

More Releases from Shareholders Foundation

Investigation announced for Long Term Investors in shares of J2 Global, Inc. (NA …
An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of J2 Global, Inc.. Investors who are current long term investors in J2 Global, Inc. (NASDAQ: JCOM) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: JCOM stocks follows a lawsuit filed against J2
Deadline on November 2, 2020 coming up in Lawsuit for Investors in shares of Ult …
A deadline is coming up on November 2, 2020 in the lawsuit filed for certain investors of Ultra Petroleum Corp (OTC: UPLCQ) over alleged securities laws violations by Ultra Petroleum Corp. Investors who purchased shares of Ultra Petroleum Corp (OTC: UPLCQ) have certain options and there are strict and short deadlines running. Deadline: November 2, 2020. OTC: UPLCQ stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Investigation announced for Long-Term Investors in shares of Lizhi Inc. (NASDAQ: …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Lizhi Inc. Investors who purchased shares of Lizhi Inc. (NASDAQ: LIZI) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Lizhi Inc. (NASDAQ: LIZI officers and directors breached their fiduciary duties and caused damage to the company and its shareholders. China based
Investigation announced for Long-Term Investors in shares of Funko, Inc. (NASDAQ …
Certain directors of Funko, Inc. are under investigation over potential breaches of fiduciary duties. Investors who purchased shares of Funko, Inc. (NASDAQ: FNKO) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Funko, Inc. directors breached their fiduciary duties and caused damage to the company and its shareholders. On March 10, 2020, a lawsuit was filed

All 5 Releases


More Releases for Endo

Global Diclofenac Patches Market 2020|, Acorda Therapeutics, Endo International, …
LOS ANGELES, United States: Considering the growth factors of pharma and Healthcare industry, QY Research has recently published a report, titled “Global Diclofenac Patches Market Research Report 2020". The research report gives the potential headway openings that prevails in the global market. The report is amalgamated depending on research procured from primary and secondary information. The global Diclofenac Patches market is relied upon to develop generously and succeed in volume
Worldwide Transdermal Drug Delivery Systems Industry 2018 | Top Players- Endo In …
The Global TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET is fragmented based on type of delivery system and application. On the basis of type, it is grouped into active and passive delivery systems. The passive delivery systems are additionally divided into reservoir system and matrix system. Active delivery systems are sorted into structure based, electrical based and others. By application, it is separated into hormone replacement therapy, motion sickness, smoking cessation, analgesics,
Global Perphenazines Market 2018 - Teva, Sandoz, Endo, Mylan
Apex Market Reports, recently published a detailed market research study focused on the “Perphenazines Market” across the global, regional and country level. The report provides 360° analysis of “Perphenazines Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Perphenazines on the basis of
Global Polypectomy Snares Market 2018 - Blue Endo, Carmonja, EMED, Endo-Flex
The statistical surveying information incorporated into the Polypectomy Snares report is the aftereffect of significant essential and optional research exercises. The report fragments the worldwide market for Polypectomy Snares based on makers, item compose, applications, and Region. In this report, each fragment is contemplated completely and measurements are introduced in detail. The report offers an exact outline of the worldwide Polypectomy Snares advertise covering key factors, for example, drivers and
Polypectomy Snares Market - Blue Endo (USA), Changzhou Health Microport Medical …
Global Polypectomy Snares Market Size, Status and Forecast 2022 provides Market information about Manufacturers, Countries, Type and Application.This Industry report also states Company Profile, sales, Polypectomy Snares Market revenue and price, market share, market growth and gross margin by regions. Top Manufacturers/Key Players: Blue Endo (USA) Changzhou Health Microport Medical Devices (China) EMED (Poland) Endo-Flex (Germany) Endo-Therapeutics (USA) EndoChoice (USA) ENDOMED (Germany) Healthcare Medical Changzhou (China) Jiangsu Kangjin Medical Instruments (China) Medi-Globe (Germany) Mednova Medical Technology (China) Ovesco Endoscopy (Germany) Pauldrach Medical (Germany) Sejong
Lidocaine Patches Market 2017 - Acorda Therapeutics, Endo International, GlaxoSm …
Apex Research, recently published a detailed market research study focused on the "Lidocaine Patches Market" across the global, regional and country level. The report provides 360° analysis of "Lidocaine Patches Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Lidocaine Patches industry, and estimates the future trend of Lidocaine Patches market on